cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances

NCT05429359 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-09-06

No results posted yet for this study

Summary

Collection of venous blood samples in 50 persons with type 1 diabetes to evaluate the behavior of different biomarkers (glucose, lactate, beta-hydroxybutyrate), and hormones (cortisol, growth hormone) during and after one morning CardioPulmonary Exercise Test and 2 aerobic (90 minutes at 40-45% of VO2 max) exercise tests under different circumstances (see Protocol).

Conditions

  • Diabetes Mellitus, Type 1

Interventions

OTHER

CPET: CardioPulmonary Exercise Test for CSII users

* Baseline * VO2peak measurement * Breakfast * 100% bolus insulin * CSII users: 100% basal

OTHER

AEX1: Aerobic Exercise Test 1 for CSII users

* 90min * 40-45% VO2peak * Breakfast * 50% bolus insulin * CSII users: -2h target 150 mg/dL

OTHER

AEX2: Aerobic Exercise Test 2 for CSII users

* 90min * 40-45% VO2peak * Breakfast * 50% bolus insulin * CSII users: -1h target 150 mg/dL

OTHER

CPET: CardioPulmonary Exercise Test for MDI users

* Baseline * VO2peak measurement * Breakfast * 100% bolus insulin * MDI users: 100% basal

OTHER

AEX1: Aerobic Exercise Test 1 for MDI users

* 90min * 40-45% VO2peak * Breakfast * 50% bolus insulin * MDI users: 50% basal

OTHER

AEX2: Aerobic Exercise Test 2 for MDI users

* 90min * 40-45% VO2peak * Breakfast * 50% bolus insulin * MDI users: 80% basal

Sponsors & Collaborators

  • Universiteit Antwerpen

    collaborator OTHER
  • York University

    collaborator OTHER
  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Christophe De Block, MD, PhD · University Hospital, Antwerp

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-08-31
Completion
2024-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05429359 on ClinicalTrials.gov